Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Michel Vounatsos
Age : 58
Public asset : 14,860,447 USD
Country of residence : Unknown
Linked companies : Biogen Inc. - PerkinElmer, Inc.

Biography of Michel Vounatsos 
Michel Vounatsos is on the board of PerkinElmer, Inc. (United States), L’Institut de RYthmologie et Modélisation Cardiaque and n-Lorem Foundation and Chief Executive Officer & Director at Biogen, Inc. In his past career he occupied the position of President-Primary Care & Customer Business Line at Merck & Co., Inc. Mr. Vounatsos received an MBA from École des Hautes Études Commerciales de Paris.


Current positions of Michel Vounatsos 
Holdings of Michel Vounatsos 
Michel Vounatsos : Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
11/22MUKESH AMBANI : India's salesmen face ruin as tycoon Ambani targets mom-and-pop stores
RE
11/29ANIL AMBANI : India central bank to start bankruptcy procedure against Reliance Capital; co to comply
RE
11/29JACK DORSEY : Twitter CEO Jack Dorsey hands reins to technology chief Agrawal
RE
11/24HERBERT DIESS : Factbox-Possible successors to Volkswagen CEO Diess
RE
More news


© 2021 People and Ownership :   
Michel Vounatsos : Connections 


Latest news about Michel Vounatsos 
10/20BIOGEN : Third-Quarter Results Fall as Alzheimer's Drug Sales Miss Street Views; Full-Year Outlook Raised
MT
10/20Biogen 3Q Results Beat Expectations; Alzheimer's Drug Aduhelm Posts Sales of $300,000
DJ
09/09US Stocks Retreat as Jobless Claims Drop More Than Expected
MT
09/09US Stocks End Lower After Larger-Than-Expected Decline in Jobless Claims
MT
09/09Equities Edge Higher Midday After Jobless Claims Drop More Than Expected
MT
09/09MIDDAY REPORT : US Stocks Stall, Nasdaq Rises After Jobless Claims Drop More Than Expected
MT
07/22Biogen says uptake on new Alzheimer's drug slower than expected
RE
More news